Detalhe da pesquisa
1.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306283
2.
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
J Infect Dis
; 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019956
3.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561027
4.
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.
Clin Infect Dis
; 2023 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610728
5.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036397
6.
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med
; 383(20): 1920-1931, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663912
7.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med
; 383(25): 2427-2438, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991794
8.
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Ann Intern Med
; 175(12): 1716-1727, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442063
9.
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.
Antimicrob Agents Chemother
; 63(9)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285228
10.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet
; 391(10120): 552-562, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217376
11.
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
N Engl J Med
; 384(23): 2259-2261, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822494
12.
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med
; 384(1): 80-82, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270381
13.
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.
J Infect Dis
; 217(7): 1055-1059, 2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409017
14.
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.
Lancet
; 390(10095): 649-658, 2017 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28666680
15.
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
J Infect Dis
; 212(4): 552-61, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25649171
16.
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.
Vaccine
; 42(2): 295-309, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105137
17.
Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies.
Front Immunol
; 14: 1163550, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911714
18.
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.
Lancet Infect Dis
; 23(4): 484-495, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525985
19.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
medRxiv
; 2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034641
20.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
medRxiv
; 2023 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333252